Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 80
Selected: 0
NCT IDTitle
NCT00291590Diabetes Health Enhancement Program to Improve Health of People With Diabetes
NCT00193427Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
NCT00118053Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
NCT00193024Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
NCT00183794Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
NCT00215930The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
NCT00176059Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
NCT00211224Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
NCT00048087Iressa/Docetaxel in Non-Small-Cell Lung Cancer
NCT00279916Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
NCT01640782Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach
NCT00256789Once Weekly Radiation for Lung Cancer With Chemotherapy
NCT00148070Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
NCT00390429Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
NCT00198237Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer
NCT001896575FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer
NCT00193271Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer
NCT00221845Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
NCT00149175Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
NCT00002662Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
NCT00194740Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer
NCT00003257Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT00005800Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00190411Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
NCT00240747Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
NCT00527761Taxotere/Temodar/Cisplatin Study in Melanoma Patients
NCT00118508The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
NCT00193011Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer
NCT00113347Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00189449Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis
NCT00090610Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
NCT00122564Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
NCT00280735Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
NCT00087035Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
NCT00193180Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
NCT00118131Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00095654The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
NCT01652820Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
NCT00189670Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer
NCT00238615Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
NCT00193245Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
NCT00196651HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection
NCT00270894Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
NCT00193232Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
NCT00318890Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
NCT00214058Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
NCT00288444Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
NCT00426127Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
NCT01035528Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)
NCT00210184Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer